These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8784361)

  • 1. Failure of current guidelines for cholesterol screening in urban African-American adolescents.
    Rifai N; Neufeld E; Ahlstrom P; Rimm E; D'Angelo L; Hicks JM
    Pediatrics; 1996 Sep; 98(3 Pt 1):383-8. PubMed ID: 8784361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of AAP guidelines for cholesterol screening in youth: Project HeartBeat!
    Eissa MA; Wen E; Mihalopoulos NL; Grunbaum JA; Labarthe DR
    Am J Prev Med; 2009 Jul; 37(1 Suppl):S71-7. PubMed ID: 19524159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges to implementing the current pediatric cholesterol screening guidelines into practice.
    Dennison BA; Jenkins PL; Pearson TA
    Pediatrics; 1994 Sep; 94(3):296-302. PubMed ID: 8065853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of family history to predict high blood cholesterol among hispanic preschool children.
    Shea S; Basch CE; Irigoyen M; Zybert P; Rips JL; Contento I; Gutin B
    Prev Med; 1990 Jul; 19(4):443-55. PubMed ID: 2204914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Definition and application of the discretionary screening indicators according to the National Cholesterol Education Program for Children and Adolescents.
    Diller PM; Huster GA; Leach AD; Laskarzewski PM; Sprecher DL
    J Pediatr; 1995 Mar; 126(3):345-52. PubMed ID: 7869190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are parents' self-reported total cholesterol levels useful in identifying children with hyperlipidemia? An examination of current guidelines.
    Resnicow K; Cross D
    Pediatrics; 1993 Sep; 92(3):347-53. PubMed ID: 8361788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypercholesterolemia in adolescents: effectiveness of screening strategies based on selected risk factors.
    Steiner NJ; Neinstein LS; Pennbridge J
    Pediatrics; 1991 Aug; 88(2):269-75. PubMed ID: 1861925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poor performance of body mass index as a marker for hypercholesterolemia in children and adolescents.
    Lee JM; Gebremariam A; Card-Higginson P; Shaw JL; Thompson JW; Davis MM
    Arch Pediatr Adolesc Med; 2009 Aug; 163(8):716-23. PubMed ID: 19652103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designing a simpler high blood cholesterol case detection strategy: are the advantages of the NCEP protocol worth the complexity?
    Hofer T; Weissfeld J
    Med Decis Making; 1994; 14(4):357-68. PubMed ID: 7808210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of the American Academy of Pediatrics recommendations for identifying youths with hypercholesterolemia.
    O'Loughlin J; Lauzon B; Paradis G; Hanley J; Lévy E; Delvin E; Lambert M
    Pediatrics; 2004 Jun; 113(6):1723-7. PubMed ID: 15173497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary risk factors in adolescents related to their knowledge of familial coronary heart disease and hypercholesterolemia: the Muscatine Study.
    Muhonen LE; Burns TL; Nelson RP; Lauer RM
    Pediatrics; 1994 Mar; 93(3):444-51. PubMed ID: 8115204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward the prevention of coronary heart disease: screening of children and adolescents for high blood cholesterol.
    Reece SM
    Nurse Pract; 1995 Feb; 20(2):22, 24-6, 31 passim. PubMed ID: 7715864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE.
    Jellinger PS; Handelsman Y; Rosenblit PD; Bloomgarden ZT; Fonseca VA; Garber AJ; Grunberger G; Guerin CK; Bell DSH; Mechanick JI; Pessah-Pollack R; Wyne K; Smith D; Brinton EA; Fazio S; Davidson M
    Endocr Pract; 2017 Apr; 23(Suppl 2):1-87. PubMed ID: 28437620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid measurements in the management of cardiovascular diseases: Practical recommendations a scientific statement from the national lipid association writing group.
    Wilson PWF; Jacobson TA; Martin SS; Jackson EJ; Le NA; Davidson MH; Vesper HW; Frikke-Schmidt R; Ballantyne CM; Remaley AT
    J Clin Lipidol; 2021; 15(5):629-648. PubMed ID: 34802986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of Canadian and American guidelines for lipid management using data from the National Cholesterol Education Program Evaluation ProjecT Utilizing Novel E-technology (NEPTUNE) II survey.
    Maki KC; Davidson MH; Dicklin MR
    Can J Cardiol; 2006 Mar; 22(4):315-22. PubMed ID: 16568156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low high-density lipoprotein cholesterol and other coronary heart disease risk factors in patients with total cholesterol levels greater than 5.17 mmol/L (200 mg/dL) in family practice. A report from CEN.
    J Am Board Fam Pract; 1991; 4(5):285-97. PubMed ID: 1746296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of treatment with fluvastatin extended-release 80-mg tablets and immediate-release 40-mg capsules in patients with primary hypercholesterolemia.
    Isaacsohn JL; LaSalle J; Chao G; Gonasun L
    Clin Ther; 2003 Mar; 25(3):904-18. PubMed ID: 12852707
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.